189 results match your criteria: "Rwanda Biomedical centre[Affiliation]"

Article Synopsis
  • Antimicrobial resistance in neonatal sepsis is increasing in low- and middle-income countries, making treatment difficult due to poorly understood resistance mechanisms that spread between bacteria.
  • The BARNARDS network studied 36,285 neonates from seven LMICs, finding Klebsiella pneumoniae as the leading cause of sepsis, along with several other bacteria.
  • Whole-genome sequencing revealed that many isolated bacteria had multiple antibiotic resistance genes and were resistant to treatments used for neonatal sepsis, highlighting a need for improved research and therapies.
View Article and Find Full Text PDF

Background: To eliminate hepatitis C, Rwanda is conducting national mass screenings and providing to people with chronic hepatitis C free access to Direct Acting Antivirals (DAAs). Until 2020, prescribers trained and authorized to initiate DAA treatment were based at district hospitals, and access to DAAs remains expensive and geographically difficult for rural patients. We implemented a mobile clinic to provide DAA treatment initiation at primary-level health facilities among people with chronic hepatitis C identified through mass screening campaigns in rural Kirehe and Kayonza districts.

View Article and Find Full Text PDF
Article Synopsis
  • Two cases are discussed where the Xpert MTB/RIF test incorrectly indicated rifampicin-resistant tuberculosis.
  • This false result was linked to low cycle thresholds and missing probes in the test.
  • The findings suggest a need for improvements in the Xpert MTB/RIF testing method.
View Article and Find Full Text PDF

Background: Podoconiosis is a progressive swelling of the legs affecting genetically susceptible people who live in areas with irritant red clay soils and walk barefoot. The disease is a public health concern in many countries, including Rwanda.

Methods: This retrospective study described individual and familial characteristics of patients with podoconiosis attending the Heart and Sole Africa (HASA) clinics in Rwanda.

View Article and Find Full Text PDF

Suppressing infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will probably require the rapid identification and isolation of individuals infected with the virus on an ongoing basis. Reverse-transcription polymerase chain reaction (RT-PCR) tests are accurate but costly, which makes the regular testing of every individual expensive. These costs are a challenge for all countries around the world, but particularly for low-to-middle-income countries.

View Article and Find Full Text PDF

Background: Helping Babies Breathe (HBB) is a competency-based educational method for an evidence-based protocol to manage birth asphyxia in low resource settings. HBB has been shown to improve health worker skills and neonatal outcomes, but studies have documented problems with skills retention and little evidence of effectiveness at large scale in routine practice. This study examined the effect of complementing provider training with clinical mentorship and quality improvement as outlined in the second edition HBB materials.

View Article and Find Full Text PDF
Article Synopsis
  • Artemisinin resistance, marked by delayed clearance of P. falciparum after treatment, has been prevalent in Southeast Asia but hasn't been observed in Africa until now.
  • A study in Rwanda identified the Pfkelch13 R561H mutation in 7.4% of patients, suggesting it may be linked to artemisinin resistance.
  • This finding indicates the emergence of this resistance mechanism in Africa, which could threaten the effectiveness of current antimalarial treatments.
View Article and Find Full Text PDF

We report a case of acquired fluoroquinolone (FQ) resistance under short-course multidrug-resistant tuberculosis (MDR-TB) treatment. The patient was managed at Kabutare hospital, one of the two specialized MDR-TB clinics in Rwanda. A low dose of moxifloxacin was used in the first three critical months.

View Article and Find Full Text PDF
Article Synopsis
  • The World Health Organisation released ICD-11 in 2019, allowing its integration with Electronic Medical Records (EMR) through technologies like API.
  • In Rwanda, ICD-11 was tested in two healthcare facilities from July to October 2019, showing that adapting the API in EMR is feasible with over 50% of diagnoses recorded using it.
  • Healthcare providers found ICD-11 easy to learn and beneficial for standardizing diagnoses, improving data reporting, and facilitating insurance reimbursement, suggesting it could be expanded to all hospitals in Rwanda and similar systems elsewhere.
View Article and Find Full Text PDF
Article Synopsis
  • The Xpert MTB/RIF assay is widely used to quickly diagnose tuberculosis and identify rifampicin resistance, but this study examines how often false-positive rifampicin resistance results occur.
  • Conducted in Rwanda, the study involved patients with initial positive results and included repeat testing and advanced sequencing to clarify actual resistance status.
  • Of the 154 patients retested, 47% were found to have false-positive results for rifampicin resistance, while a subset of those with true resistance also had issues being confirmed by the initial Xpert test.
View Article and Find Full Text PDF
Article Synopsis
  • Injuries contribute significantly to disability and death in low- and middle-income countries, where timely access to care is often hindered by various barriers throughout the recovery process.* ! -
  • A workshop in Kigali, Rwanda, identified 42 barriers to injury care access, with the top four being the need for specialist staff training, greater health education on injury severity, improved geographical reach of trauma centers, and established referral protocols.* ! -
  • Addressing these barriers requires a comprehensive strategy that covers the entire patient journey from injury to rehabilitation, providing valuable insights for researchers and policymakers in planning effective interventions.* !
View Article and Find Full Text PDF

Background: Rwanda conducted a national tuberculosis (TB) prevalence survey to determine the magnitude of TB in the country and determine to what extent the national surveillance system captures all TB cases. In addition we measured the patient diagnostic rate, comparing the measured TB burden data with the routine surveillance data to gain insight into how well key population groups are being detected.

Methods: A national representative nationwide cross-sectional survey was conducted in 73 clusters in 2012 whereby all enrolled participants (residents aged 15 years and above) were systematically screened for TB by symptoms and chest X-ray (CXR).

View Article and Find Full Text PDF

In 2005, in response to the increasing prevalence of rifampicin-resistant tuberculosis (RR-TB) and poor treatment outcomes, Rwanda initiated the programmatic management of RR-TB, including expanded access to systematic rifampicin drug susceptibility testing (DST) and standardised treatment. To describe trends in diagnostic and treatment delays and estimate their effect on RR-TB mortality. Retrospective analysis of individual-level data including 748 (85.

View Article and Find Full Text PDF

CD4+ regulatory T cells and CD4+ activated T cells in new active and relapse tuberculosis.

Cell Mol Biol (Noisy-le-grand)

December 2019

Center for Human Genetics, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

The aim of the present study was to examine characteristics of tuberculosis (TB) patients with different clinical forms and to study the frequency of Regulatory T cells (Treg cells) and Activated T cells in patients with new active and relapse TB. Forty-five pulmonary TB patients and a control group of 15 healthy individuals were enrolled in this study. Of the 45 TB patients, 15 were new cases with drug-susceptible active TB and 30 were relapsed cases (15 drug-susceptible and 15 multidrug resistant-TB).

View Article and Find Full Text PDF

Background: The 1994 Genocide against the Tutsi was a major traumatic event affecting nearly all Rwandans. Significant psychological sequels continue to occur in the population 25 years after, with a high prevalence of posttraumatic stress disorder (PTSD) found in women. Three groups are typically designated with regard to the Genocide against the Tutsi: those who were targeted and categorized as genocide "survivors," those who were in the country during the genocide and were the "non-targeted" group, and those who were outside of the country, referred to as the "1959 returnees.

View Article and Find Full Text PDF

Purpose: Feasible and effective strategies are needed to facilitate earlier diagnosis of breast cancer in low-income countries. The goal of this study was to examine the impact of health worker breast health training on health care utilization, patient diagnoses, and cancer stage in a rural Rwandan district.

Methods: We conducted a cluster randomized trial of a training intervention at 12 of the 19 health centers (HCs) in Burera District, Rwanda, in 2 phases.

View Article and Find Full Text PDF

Seroreactivity to Chikungunya and West Nile Viruses in Rwandan Blood Donors.

Vector Borne Zoonotic Dis

October 2019

Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Chikungunya virus (CHIKV) and West Nile virus (WNV) have previously been reported from several African countries, including those bordering Rwanda where they may have originated. However, there have been no serosurveillance reports from Rwanda regarding these two viral pathogens. In this article, we present the first study of immunoglobulin G (IgG) seroreactivity of CHIKV and WNV in Rwandan blood donor samples.

View Article and Find Full Text PDF

The study aim was to describe human papillomavirus (HPV)-attributable cancer burden in Rwanda, according to anogenital cancer site, HPV type, age and HIV status. Tissue specimens of cervical, vulvar, vaginal, penile and anal cancer diagnosed in 2012-2018 were retrieved from three cancer referral hospitals and tested for high-risk (HR) HPV DNA. Cervical cancer represented the majority of cases (598 of 738), of which 96.

View Article and Find Full Text PDF

Objective: To determine prevalent MDR-TB genotypes and describe treatment outcome and bacteriology conversion in MDR-TB patients.

Methods: Review of laboratory records of 173 MDR-TB patients from all over Rwanda who initiated treatment under programmatic management of MDR-TB (PMDT) between 2014 and 2015. Fifty available archived isolates were genotyped by mycobacterial interspersed repetitive units - variable number of tandem repeats (MIRU-VNTR) genotyping.

View Article and Find Full Text PDF

Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study.

BMC Infect Dis

April 2019

Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Spitalstrasse 12, 1st floor, CH-4031, Basel, Switzerland.

Background: Currently, there is limited evidence on the effectiveness of second-line antiretroviral therapy (ART) in sub-Saharan Africa. To address this challenge, outcomes of second-line protease inhibitor (PI) based ART in Rwanda were assessed.

Methods: A two-stage cluster sampling design was undertaken.

View Article and Find Full Text PDF

Schistosomiasis is prevalent in many sub-Saharan African countries and transmission is through waters contaminated by infected snails. In Rwanda, although schistosomiasis is endemic, very few epidemiological studies exist; of these, schoolchildren have been the focus, neglecting pre-school-aged children (PSAC). Furthermore, malacological surveys to indicate the potential for transmission are scarce in the country.

View Article and Find Full Text PDF

Background: To achieve the ambitious 90-90-90 UNAIDS targets, access to routine viral load (VL) is critical. To measure VL, Rwanda has relied on a national reference laboratory for years. In 2014, a VL testing platform was implemented in a rural District in the Northern Province.

View Article and Find Full Text PDF

Background: Despite the widespread use of antenatal care (ANC), its effectiveness in low-resource settings remains unclear. In this study, self-reported health-related quality of life (HRQoL) was used as an alternative to other maternal health measures previously used to measure the effectiveness of antenatal care. The main objective of this study was to determine whether adequate antenatal care utilization is positively associated with women's HRQoL.

View Article and Find Full Text PDF